Literature DB >> 23124102

Defining vascular aging and cardiovascular risk.

Stéphane Laurent1.   

Abstract

Whereas vascular aging has been identified as an emerging cardiovascular risk factor, definitions of 'normal' and 'early' vascular aging (EVA) and their precise relationship with cardiovascular risk are currently equivocal. The present review discusses the concept of vascular aging; that structural and functional changes occur in the large arteries with aging; and EVA; that such age-associated changes are accelerated in individuals at increased cardiovascular risk; and their metrics; indeed, in order to provide a definition of when EVA occurs in clinical practice, reference values of normal and accelerated vascular aging are needed. Due to the complex nature of age-associated changes in the large arteries described above, there are different parameters relating to vascular aging which can be measured. These broadly include aortic and carotid stiffening; aortic and carotid lumen dilation; endothelial dysfunction (usually measured via brachial flow-mediated dilatation); and carotid intima-media thickness.

Mesh:

Year:  2012        PMID: 23124102     DOI: 10.1097/HJH.0b013e328353e501

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  32 in total

1.  Aortic pulse wave velocity in individuals of Asian and African ancestry: the HELISUR study.

Authors:  Frederieke S Diemer; Se-Sergio M Baldew; Yentl C Haan; Fares A Karamat; Glenn P Oehlers; Gert A van Montfrans; Bert-Jan H van den Born; Ron J G Peters; Lenny M W Nahar-Van Venrooij; Lizzy M Brewster
Journal:  J Hum Hypertens       Date:  2018-12-19       Impact factor: 3.012

2.  Are the leukocyte telomere length attrition and telomerase activity alteration potential predictor biomarkers for sporadic TAA in aged individuals?

Authors:  Carmela R Balistreri; Calogera Pisano; Adriana Martorana; Oreste F Triolo; Domenico Lio; Giuseppina Candore; Giovanni Ruvolo
Journal:  Age (Dordr)       Date:  2014-08-17

3.  Differential effects of relaxin deficiency on vascular aging in arteries of male mice.

Authors:  Maria Jelinic; Marianne Tare; Kirk P Conrad; Laura J Parry
Journal:  Age (Dordr)       Date:  2015-06-25

4.  A positive association between stroke risk and sarcopenia in men aged ≥ 50 years, but not women: results from the Korean National Health and Nutrition Examination Survey 2008-2010.

Authors:  S Park; J-O Ham; B-K Lee
Journal:  J Nutr Health Aging       Date:  2014-11       Impact factor: 4.075

Review 5.  Contributions of Nonhuman Primates to Research on Aging.

Authors:  E S Didier; A G MacLean; M Mohan; P J Didier; A A Lackner; M J Kuroda
Journal:  Vet Pathol       Date:  2016-02-11       Impact factor: 2.221

Review 6.  In Development-A New Paradigm for Understanding Vascular Disease.

Authors:  Nicholas A Flavahan
Journal:  J Cardiovasc Pharmacol       Date:  2017-05       Impact factor: 3.105

7.  Superoxide inhibition restores endothelium-dependent dilatation in aging arteries by enhancing impaired adherens junctions.

Authors:  Fumin Chang; Sheila Flavahan; Nicholas A Flavahan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-01-12       Impact factor: 4.733

8.  The relationships between visit-to-visit blood pressure variability and renal and endothelial function in chronic kidney disease.

Authors:  Chikara Nakano; Satoshi Morimoto; Mitsutaka Nakahigashi; Makiko Kusabe; Hiroko Ueda; Kazunori Someya; Atsuhiro Ichihara; Toshiji Iwasaka; Ichiro Shiojima
Journal:  Hypertens Res       Date:  2014-12-04       Impact factor: 3.872

9.  Impaired activity of adherens junctions contributes to endothelial dilator dysfunction in ageing rat arteries.

Authors:  Fumin Chang; Sheila Flavahan; Nicholas A Flavahan
Journal:  J Physiol       Date:  2017-06-30       Impact factor: 5.182

10.  Local renin-angiotensin system mediates endothelial dilator dysfunction in aging arteries.

Authors:  Sheila Flavahan; Fumin Chang; Nicholas A Flavahan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-07-15       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.